Cargando…
The potential of hyperpolarised (13)C-MRI to target glycolytic tumour core in prostate cancer
ABSTRACT: Hyperpolarised [1-(13)C]pyruvate MRI (HP-(13)C-MRI) is an emerging metabolic imaging technique that has shown promise for evaluating prostate cancer (PCa) aggressiveness. Accurate tumour delineation on HP-(13)C-MRI is vital for quantitative assessment of the underlying tissue metabolism. H...
Autores principales: | Sushentsev, Nikita, McLean, Mary A., Warren, Anne Y., Brodie, Cara, Jones, Julia, Gallagher, Ferdia A., Barrett, Tristan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474577/ https://www.ncbi.nlm.nih.gov/pubmed/35731287 http://dx.doi.org/10.1007/s00330-022-08929-7 |
Ejemplares similares
-
Hyperpolarised (13)C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2022) -
Author Correction: Hyperpolarised (13)C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2022) -
The use of hyperpolarised (13)C-MRI in clinical body imaging to probe cancer metabolism
por: Woitek, Ramona, et al.
Publicado: (2021) -
(13)C Pyruvate Transport Across the Blood-Brain Barrier in Preclinical Hyperpolarised MRI
por: Miller, Jack J., et al.
Publicado: (2018) -
MRI with hyperpolarised [1-(13)C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model
por: Serrao, Eva M, et al.
Publicado: (2016)